Third, the variable disease progression observed even within monogenic disorders highlights a critical need for robust stratification biomarkers, such as metabolomic signatures, mitochondrial DNA copy number, circulating cell-free mtDNA levels, and quantitative imaging metrics (OCT for optic neuropathies, FDG-PET for AD), to identify patients within optimal therapeutic windows
Public health campaigns that target obesity and metabolic diseases also drive this market, opening up new growth prospects
The right choice depends on your health profile, your weight loss goals, your budget, and your tolerance for newer versus more established treatments
Diet and Nutrition Considerations Adopting a balanced diet with healthy foods is important when using tesofensine for weight loss
Trends Endocrinol Metab (2021) 32:15969